Table 2

Baseline characteristics: activity and metrology

CharacteristicSpAnr-axSpAASM-W/FET p value
ASDAS-CRP, median (IQR)2.2 (1.4–2.8)2.0 (1.1–2.3)2.4 (1.7–2.8) 0.022
BASDAI, median (IQR)2.6 (1.2–4.7)2.7 (1.0–4.9)2.4 (1.2–3.7)0.362
CRP (mg/L)4.3 (1.2–12.0)2.5 (0.8–8.2)7.1 (2.6–14.9) <0.001
ESR (mm/h)8.0 (4.0–17.8)7.0 (3.0–16.0)12.0 (4.4–22.0) 0.007
BASFI, median (IQR)1.4 (0.5–2.1)1.1 (0.3–2.9)1.8 (0.7–3.3) 0.030
Metrology
 Modified Schober (cm), median (IQR)4.0 (3.0–5.0)4.5 (3.5–5.5)4.0 (3.0–5.0) <0.001
 Occiput to wall (cm), median (IQR)0.0 (0.0–0.0)0.0 (0.0–0.0)0.0 (0.0–0.0) <0.001
 Chin–chest distance (cm), median (IQR)1.5 (0.0–3.0)1.0 (0.0–2.0)2.0 (0.0–3.0) 0.008
 Chest expansion (cm), median (IQR)4.0 (3.0–6.0)4.0 (3.0–6.0)3.8 (2.0–6.0)0.136
  • AS, ankylosing spondylitis; ASDAS-CRP, Ankylosing Spondylitis Disease Activity Score based on CRP; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, Bath Ankylosing Spondylitis Functional Index; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; M-W/FETp, Mann-Whitney/Fisher exact test p value; nr-axSpA, non-radiographic axial spondyloarthritis; SpA, spondyloarthritis.